Combination Treatment of Biochanin A and Atorvastatin Alters Mitochondrial Bioenergetics, Modulating Cell Metabolism and Inducing Cell Cycle Arrest in Pancreatic Cancer Cells
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Combination therapy with biochanin A and atorvastatin shows promise against pancreatic cancer. This treatment enhanced apoptosis and reduced cell proliferation and invasiveness in pancreatic cancer cells.
Area Of Science
- Oncology
- Molecular Biology
- Pharmacology
Background
- Pancreatic cancer has a very low survival rate, with limited success from current treatments like gemcitabine.
- Isoflavones (e.g., biochanin A) and statins (e.g., atorvastatin) show potential anti-cancer and anti-proliferative effects, respectively.
Purpose Of The Study
- To investigate the combined effects of biochanin A and atorvastatin on pancreatic cancer cells.
- To evaluate the impact of this combination therapy on cell viability, apoptosis, metabolism, cell signaling, cell cycle, and invasiveness.
Main Methods
- Utilized pancreatic cancer cell lines (AsPC-1, PANC-1, MIA PaCa-2).
- Assessed cell viability (MTT, cell count), apoptosis (flow cytometry), metabolism (Seahorse assays), signaling pathways and cell cycle proteins (Western blot), and invasiveness (gelatin zymography).
Main Results
- Combination treatment significantly decreased cell survival and increased apoptosis compared to single agents.
- Reduced invasiveness, STAT3 activation, and cell cycle progression mediators were observed in PANC-1 cells.
- The combination therapy differentially inhibited respiratory complexes in pancreatic cancer cells.
Conclusions
- Combined biochanin A and atorvastatin demonstrate enhanced anti-cancer activity in pancreatic cancer cells.
- The treatment effectively induces apoptosis, down-regulates cell cycle proteins, and reduces invasiveness.
- This combination therapy warrants further investigation for novel pancreatic cancer treatments.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...